Company intelligence / Profile preview

RCM Capital Management

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

RCM Capital Management was an investment management firm rather than a biotechnology, pharmaceutical, or healthcare operating company. Historical references show that it had a healthcare investment practice, including coverage of biotechnology and management of sector-focused funds such as RCM Biotechnology Fund and RCM Wellness Fund, but its core business was asset management. The firm does not appear to have developed therapeutic products, clinical programs, or a drug pipeline. Based on the available evidence, it should be classified as a financial services company with historical exposure to healthcare investing, not as a life sciences developer or healthcare operating business.

Industry: Investors

Beyond the preview

Go deeper on RCM Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RCM Capital Management.

Explore the full profile